Electroencephalogram Alpha Oscillations in Stroke Recovery: Insights into Neural Mechanisms from Combined Transcranial Direct Current Stimulation and Mirror Therapy in Relation to Activities of Daily Life.
Chia-Lun LiuYa-Wen TuMing-Wei LiKu-Chou ChangChih-Hung ChangChih-Kuang ChenChing-Yi WuPublished in: Bioengineering (Basel, Switzerland) (2024)
The goal of stroke rehabilitation is to establish a robust protocol for patients to live independently in community. Firstly, we examined the impact of 3 hybridized transcranial direct current stimulation (tDCS)-mirror therapy interventions on activities of daily life (ADL) in stroke patients. Secondly, we explored the underlying therapeutic mechanisms with theory-driven electroencephalography (EEG) indexes in the alpha band. This was achieved by identifying the unique contributions of alpha power in motor production to ADL in relation to the premotor cortex (PMC), primary cortex (M1), and Sham tDCS with mirror therapy. The results showed that, although post-intervention ADL improvement was comparable among the three tDCS groups, one of the EEG indexes differentiated the interventions. Neural-behavioral correlation analyses revealed that different types of ADL improvements consistently corresponded with alpha power in the temporal lobe exclusively in the PMC tDCS group (all r s > 0.39). By contrast, alterations in alpha power in the central-frontal region were found to vary, with ADL primarily in the M1 tDCS group ( r = -0.6 or 0.7), with the benefit depending on the complexity of the ADL. In conclusion, this research suggested two potential therapeutic mechanisms and demonstrated the additive benefits of introducing theory-driven neural indexes in explaining ADL.
Keyphrases
- transcranial direct current stimulation
- working memory
- functional connectivity
- physical activity
- randomized controlled trial
- atrial fibrillation
- end stage renal disease
- resting state
- chronic kidney disease
- ejection fraction
- newly diagnosed
- healthcare
- magnetic resonance
- mental health
- clinical trial
- magnetic resonance imaging
- brain injury
- computed tomography
- cell therapy
- double blind
- mesenchymal stem cells